Interstitial pneumonitis associated with infliximab therapy in a rheumatoid arthritis patient / 대한내과학회지
Korean Journal of Medicine
;
: 215-218, 2010.
Artigo
em Coreano
| WPRIM
| ID: wpr-102104
ABSTRACT
Tumor necrosis factor (TNF)-alpha inhibitors are well-established biological agents for the treatment of a wide variety of chronic autoimmune diseases and inflammatory conditions, including rheumatoid arthritis (RA), ankylosing spondylitis, and psoriatic arthritis. Although these drugs have been noted to have good safety profiles, some important side effects, including infection, injection site reactions, lupus-like syndrome, congestive heart failure, and malignancies have been reported. Therefore, utilization of TNF-alpha inhibitors demands caution. Interstitial pneumonitis is a very rare complication of TNF-alpha inhibitors. We report here a 71-year-old man with RA who developed interstitial pneumonitis after the third infusion of infliximab.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Artrite Reumatoide
/
Doenças Autoimunes
/
Espondilite Anquilosante
/
Artrite Psoriásica
/
Fator de Necrose Tumoral alfa
/
Doenças Pulmonares Intersticiais
/
Infliximab
/
Insuficiência Cardíaca
/
Anticorpos Monoclonais
Limite:
Idoso
/
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Ano de publicação:
2010
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS